Literature DB >> 27113788

Alternating hemiparesis and orolingual apraxia as manifestations of methotrexate neurotoxicity in a paediatric case of acute lymphoblastic leukaemia.

Siew Mei Yap1, Peter MacEneaney2, Clodagh Ryan3, Orna O'Toole1.   

Abstract

A 15-year-old girl with a recent diagnosis of acute lymphoblastic leukaemia was admitted to hospital with pancytopaenia after having received high-dose intrathecal methotrexate 1 day prior. During the next week she had intermittent episodes of alternating hemiparesis associated with speech arrest lasting minutes to hours at a time. The episodes were not associated with altered level of consciousness or headache. MRI of the brain showed features consistent with methotrexate encephalopathy. This report discusses the typical clinical and radiological features of methotrexate neurotoxicity in addition to differential diagnoses and the proposed pathophysiological mechanisms. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27113788      PMCID: PMC4854152          DOI: 10.1136/bcr-2016-214677

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.

Authors:  D H Mahoney; J J Shuster; R Nitschke; S J Lauer; C P Steuber; N Winick; B Camitta
Journal:  J Clin Oncol       Date:  1998-05       Impact factor: 44.544

Review 2.  Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia.

Authors:  Avinoam Shuper; Batia Stark; Liora Kornreich; Ian J Cohen; Gali Avrahami; Isaac Yaniv
Journal:  Isr Med Assoc J       Date:  2002-11       Impact factor: 0.892

3.  Diffusion-weighted MR imaging of early methotrexate-related neurotoxicity in children.

Authors:  Michael J Fisher; Zarir P Khademian; Erin M Simon; Robert A Zimmerman; Larissa T Bilaniuk
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

4.  Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI.

Authors:  W Küker; P Bader; U Herrlinger; S Heckl; T Nägele
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

5.  Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome.

Authors:  Nancy Rollins; Naomi Winick; Robert Bash; Timothy Booth
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

6.  Disseminated necrotizing leukoencephalopathy following low-dose oral methotrexate.

Authors:  S Raghavendra; M D Nair; T Chemmanam; T Krishnamoorthy; V V Radhakrishnan; A Kuruvilla
Journal:  Eur J Neurol       Date:  2007-03       Impact factor: 6.089

7.  Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis.

Authors:  Jose Manuel Vagace; Cristina Caceres-Marzal; Mercedes Jimenez; Maria Soledad Casado; Silvia Gonzalez de Murillo; Guillermo Gervasini
Journal:  Am J Hematol       Date:  2011-01       Impact factor: 10.047

8.  Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia.

Authors:  J E Rubnitz; M V Relling; P L Harrison; J T Sandlund; R C Ribeiro; G K Rivera; S J Thompson; W E Evans; C H Pui
Journal:  Leukemia       Date:  1998-08       Impact factor: 11.528

9.  Leukoencephalopathy in childhood hematopoietic neoplasm caused by moderate-dose methotrexate and prophylactic cranial radiotherapy--an MR analysis.

Authors:  K Matsumoto; S Takahashi; A Sato; M Imaizumi; S Higano; K Sakamoto; H Asakawa; K Tada
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-07-15       Impact factor: 7.038

10.  Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma.

Authors:  L J Rubinstein; M M Herman; T F Long; J R Wilbur
Journal:  Cancer       Date:  1975-02       Impact factor: 6.860

View more
  1 in total

1.  Methotrexate encephalopathy: Two cases in adult cancer patients, who recovered with pathophysiologically based therapy.

Authors:  Shodeinde A Coker; David A Pastel; Melissa C Davis; Elizabeth M Bengtson; Camilo E Fadul; Lionel D Lewis
Journal:  SAGE Open Med Case Rep       Date:  2017-05-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.